Australian Centre for HIV and Hepatitis Virology Research
Cunningham, Kim, Jackson, Dyer, Jones, Fernandez
TLR2 agonist - HIV peptide induction of the Th17 responses: A new immunotherapeutic and vaccine strategy?
$113,000
Australasian Paediatric Endocrine Group
M Poon
The role of environmental factor in the development of microvascular and macrovascular complications in type 1 diabetes - a 14 year follow up of an incidnet cohort
$25,000
Australian Research Council
Y Zurynski, E Elliott, H Leonard, J Christodoulou
Psychosocial and economic impacts of rare diseases on Australian children, families and health professionals
$316,780
Australian Research Council
K North
Molecular dissection of the functional regions of genes that encode actinins (ACTN2 and ACTN3) and their contribution to normal variation in skeletal muscle function
$300,000
Australian Research Council
A Tong
Protecting equity and ethics in organ donation: patient, public and professional perspectives
$375,000
Australian Orthopaedic Association Research Foundation
D Little
BMP-2 and Bisphosphonate treatment of Avascular Necrosis in Piglet model
$32,725
Children’s Tumor Foundation
D Little
The use of MEK ibhibitors in Nf1 pseudarthrosis
$30,000
Clive and Vera Ramaciotti Foundation
L Lau
MYCN/c-MYC-mediated regulation of the telomerase complex in neuroblastoma
$74,800
Clive and Vera Ramaciotti Foundation
J Ayer
Mechanism of action of Adiponectin.
$75,000
Foundation for Children
P Caldwell
Randomised controlled trial of timed voiding using an alarm watch vs standard watch for the treatment of daytime urinary incontinence in children
$163,920
Diabetes Australia Research Trust
M Poon
The role of environmental factors in the development of microvascular and macrovascular complications in type 1 diabetes – a 14 year follow up of an incident cohort
$60,000
IRSF Research grant
J Christodoulou
Rett Syndrome Foundation MECP2 Database (RettBASE)
$35,165
MS Research Australia
F Brilot, R Dale
Autoantibody in the first episode of demyelination, and risk of progression to MS in Australian children
$50,000
National Health & Medical Research Council
D Little, J Cooper-White, A Ruys, A Schindeler
Pre-clinical validation of a novel implant for bone tissue engineering
$421,175
National Health & Medical Research Council
K North, N Laing, K Nowak,N Clarke, M Buckley
Neuromuscular disorders: Gene discovery and disease mechanism
$772,350
National Health & Medical Research Council
E Elliott, J Latimer, C Bower, J Fitzpatrick, A Martiniuk
The Lililwan Project: Prevalence of Fetal Alcohol Spectrum Disorders in the Fitzroy Valley
$1,024,474
National Health & Medical Research Council
R Skinner, S Cooper, K McCaffery, G Zimet, K McGeehan, P Whyte, D Regan
Randomised Controlled Evaluation of a Complex Intervention to Promote Uptake of School-based HPV Vaccination
$723,634
National Health & Medical Research Council
C Jones, S Alexander
Defining the contribution of skin gamma delta T cells to cutaneous immunosurveillance, immunity and disease after HSV infection.
$581,010
National Health & Medical Research Council
J Christodoulou, S Cooper
Gene Discovery and Functional Studies to Reveal Mechanisms Underlying Mitochondrial Respiratory Chain Disorders.
$368,510
National Health & Medical Research Council
S Alexander,K Dwyer, YM Wang
Role of Purines in renal and transplant injury
$539,610
National Health & Medical Research Council
I Alexander, P Tam, G Yeoh, D Russell
Cellular therapy for genetic liver disease exploiting induced pluripotent stem cells and liver progenitor cells
$770,175
National Health & Medical Research Council
I Alexander, S Ranganathan, M Cavazzana-Calvo
Analysis and manipulation of the genome-wide integration signatures of gamma-retroviral and lentiviral vectors in human haematopoietic stem cells
$591,125
National Health & Medical Research Council
N Laing, K North, N Clarke
Approaches to therapy for the skeletal muscle actin diseases.
$881,175
National Health & Medical Research Council
K O’Grady, A Chang, K Grimwood, P Morris, H Smith-Vaughan, E Mulholland, P Torzillo, A Cripps, N Wood, A Revell
A multi-centre, double blind randomised controlled trial to evaluate the efficacy of 10 valent pneumococcal –Protein D conjugate vaccine in reducing respiratory exacerbations in children aged 18 months with suppuratives lung disease
$1,122,492
National Health & Medical Research Council
R Andrews, K O’Grady, T Nolan, P Richmond, N Wood, S Lambert, M Chatfield
FluMuM: a prospective cohort study of mother-infant pairs assessing the effectiveness of maternal influenza vaccination in prevention of influenza in early infancy
$2,481,063
National Health & Medical Research Council
C Semsarian, D Winlaw
Genetic Basis of Valvular Heart Disease
$434,255
National Health & Medical Research Council
E Banks, S Eades, C D’Este, S Bailey, S Redman, A Williamson, A Purcell, H Gunasekera, P McIntyre, K Clapham
Longitudinal investigation of health outcomes in urban Aboriginal children: SEARCH follow-up
$1,727,460
National Health & Medical Research Council
A LPonsonby, F Cameron, M Craig, A Kemp
Enterovirus, vitamin D status and inflammation at the clinical onset of type 1 diabetes in childhood
$398,047
National Health & Medical Research Council
J Couper, M Craig, P Colman, P Baghurst, W Rawlinson, T Jones, A Cotterill
Early environmental determinants of pancreatic islet autoimmunity: a pregnancy to early life cohort study in children at risk of type 1 diabetes
$1,083,720
National Health & Medical Research Council
R Heine, A Kakakios
Effect of a four-food elimination diet in children with eosinophilic oesophagitis a multi-centre, randomised controlled trial and investigation of disease mechanisms.
$520,448
National Health & Medical Research Council
LAskie , L Baur, K Campbell, L Daniels , B Taylor, LM Wen, K Hesketh, A Magarey, R Taylor, A Martin
Generating evidence of reduced rates of overweight/obesity in children: value adding to four established Australasian early intervention trials
$187,018
National Health & Medical Research Council
S Chadban, H Wu, S Alexander
Tolerance or rejection: The role of innate immunity in determining the fate of a kidney allograft.
$489,255
National Health & Medical Research Council
K North, N Laing, A Kornberg, J Burns, M Ryan,N Clarke, A Corbett, K Refshauge, M Buckley, C McLean
Centre for Research Excellence in Neuromuscular Disorders
$2,496,650
National Health & Medical Research Council
R MacIntyre, P McIntyre, R Booy, J Leask, N Wood, C Jones, R Menzies, J Kaldor, P Beutels, D Dwyer
Immunisation in understudied and special risk populations
$2,499,969
National Health & Medical Research Council
J Craig, E Banks, S Eades, C D'Este, S Bailey, S Redman, A Williamson, S Pope, C Parter, H Gunasekera
SEARCH: better evidence, better health for urban Aboriginal children
$1,395,760
Pablove Foundation
L Lau
Alternative Lengthening of Telomeres (ALT) in Neuroblastoma
$49,500
Petpetual Foundation
K North
Purchase Mobile Spectral Domain OCT System
$23,000
The Ian Potter Foundation
S Copper
To attend the 27th International Papillomavirus Conference, Berlin, Germany
$2,100
The University of Sydney
K North, I Alexander, S Alexander, J Christodoulou, D Catchpoole, N Clarke